custom tirzepatide/l-carnitine Ivím Health Tirzepatide with L-Carnitine | American

Chu M, Seltzer TF (2010) Myxedema coma induced by ingestion of raw bok choy

Bibcode:1998Natur.395..284Y

Absolute Contraindications Active malignancy Pregnancy and lactation Severe hypoglycemia disorders Known hypersensitivity to IGF-1 Active proliferative retinopathy Relative Contraindications Diabetes mellitus Renal impairment Cardiac impairment History of hyperplasia Family history of certain cancers Severe hepatic impairment Dosing & Administration Starting Dose 2050 mcg/day subcutaneously Begin at the lower end for sensitive patients Assess tolerance for 12 weeks before titration Therapeutic Range 50120 mcg/day for most indications Maximum dose: 200 mcg/day Individualize dosing based on response and tolerance Cycling Protocol 46 weeks on therapy 4 weeks off therapy Helps prevent receptor desensitization Supports long-term efficacy Administration Guidelines Hypoglycemia Prevention: Always administer IGF-1 LR3 with or shortly after carbohydrate-containing meals

Uncoupling proteins play a vital role in regulating mitochondrial membrane potential, preventing ROS production, and regulating calcium homeostasis, amongst others (Saito et al., 2009

Stanaway, J